Why Aldeyra Is A Must-Watch Stock: Exciting Catalysts On The Horizon

2023 is shaping up to be a pivotal year for Aldeyra Therapeutics Inc. (ALDX) as it continues to make significant progress in its pipeline of compounds targeting systemic and retinal immune-mediated diseases.

from RTT - Top Story https://ift.tt/csGS6MW
via IFTTT